On The Integration of Pharmacophore Model and Molecular Docking Method

被引:0
|
作者
Dong, G. [1 ]
Deng, X. J. [1 ,2 ]
Xiao, J. H. [2 ]
机构
[1] Changchun Univ Sci & Technol, Coll Comp Sci & Technol, Changchun 130022, Jilin, Peoples R China
[2] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China
关键词
molecular docking; pharmacophore model; virtual screening; point-pattern matching;
D O I
10.1260/1748-3018.5.1.129
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Structure-based molecular docking has been recognized as the most effective virtual screening technology. Two aspects decide the accuracy of virtual screening result: one is the simulation degree to the interaction of ligands and acceptors, the other is the quantitative evaluation technology to the result of interaction. The pharmacophore model is an important method of drug design, which can be used for the discovery of lead compounds. The development of scoring-technique based on the pharmacophore is an important supplement and improvement to the quantitative evaluation technology of the molecular docking result, which can enhance the accuracy and reliability of virtual screening based on the molecular docking technology, and impulse the development of new drug molecular design technique. Therefore, the Molecular Docking method of integration pharmacophore model is necessary for researching the creation of new drugs. This paper focuses on researching following content: 1) Pharmacophore of digital processing; explore the use of appropriate mathematical model to describe the specific target pharmacophore. 2) The integration of molecular docking algorithm; the development of the combination of molecular docking algorithm based on the established mathematical model of pharmacophore. 3) Establishing the verification of the reliability of the methods; through screening the results of the known activity of the compound-library, testing the reliability of the method.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [41] Ligand Based Pharmacophore Identification and Molecular Docking Studies for Grb2 Inhibitors
    Arulalapperumal, Venkatesh
    Sakkiah, Sugunadevi
    Thangapandian, Sundarapandian
    Lee, Yuno
    Meganathan, Chandrasekaran
    Hwang, Swan
    Lee, Keun Woo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (05) : 1707 - 1714
  • [42] Multidimensional Criteria for Virtual Screening of PqsR Inhibitors Based on Pharmacophore, Docking, and Molecular Dynamics
    Xiao, Haichuan
    Li, Jiahao
    Yang, Dongdong
    Du, Jiarui
    Li, Jie
    Lin, Shuqi
    Zhou, Haibo
    Sun, Pinghua
    Xu, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [43] An investigation of antidiabetic activities of bioactive compounds in Euphorbiahirta Linn using molecular docking and pharmacophore
    Quy Trinh
    Ly Le
    Medicinal Chemistry Research, 2014, 23 : 2033 - 2045
  • [44] Molecular Docking, Pharmacophore Mapping, and Virtual Screening of Novel Glucokinase Activators as Antidiabetic Agents
    Mehra, Anuradha
    Mittal, Amit
    Thakur, Divya
    CURRENT PROTEOMICS, 2024, 21 (04) : 251 - 276
  • [45] Pharmacophore model of ALS inhibitors by DISCO method
    Maio, FM
    Su, HQ
    Wang, JL
    ACTA PHYSICO-CHIMICA SINICA, 2000, 16 (10) : 926 - 931
  • [46] In Silico Design of Human IMPDH Inhibitors Using Pharmacophore Mapping and Molecular Docking Approaches
    Li, Rui-Juan
    Wang, Ya-Li
    Wang, Qing-He
    Wang, Jian
    Cheng, Mao-Sheng
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2015, 2015
  • [47] Pharmacophore modelling, virtual screening and molecular docking studies on PLD1 inhibitors
    Behera, D. K.
    Behera, P. M.
    Acharya, L.
    Dixit, A.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (12) : 991 - 1009
  • [48] Pharmacophore modeling and molecular docking studies of acridines as potential DPP-IV inhibitors
    Abu Khalaf, R.
    Jarekji, Z.
    Al-Qirim, T.
    Sabbah, D.
    Shattat, G.
    CANADIAN JOURNAL OF CHEMISTRY, 2015, 93 (07) : 721 - 729
  • [49] Exploring Proteus mirabilis Methionine tRNA Synthetase Active Site: Homology Model Construction, Molecular Dynamics, Pharmacophore and Docking Validation
    Elbaramawi, Samar S.
    Eissa, Ahmed G.
    Noureldin, Nada A.
    Simons, Claire
    PHARMACEUTICALS, 2023, 16 (09)
  • [50] Identification of Pim-1 Kinase Inhibitors by Pharmacophore Model, Molecular Docking-based Virtual Screening, and Biological Evaluation
    Huang, Jing
    Yuan, Ye
    Zhu, Xiaoxiao
    Li, Guodong
    Xu, Ya
    Chen, Wenlin
    Zhu, Ying
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2022, 18 (03) : 240 - 246